Related Experiment Video
Updated: Jun 7, 2026
10:24
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
Published on: October 5, 2011
[Differentiation of functional cells from iPS cells by efficient gene transfer]
Kenji Kawabata1, Katsuhisa Tashiro, Hiroyuki Mizuguchi
1Laboratory of Stem Cell Regulation, National Institute of Biomedical Innovation, Osaka, Japan. kawabata@nibio.go.jp
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|November 5, 2010
Summary
Adenovirus vectors efficiently deliver genes into induced pluripotent stem (iPS) cells, enhancing their differentiation into specific cell types like adipocytes or osteoblasts for regenerative medicine applications.
Area of Science:
- Stem Cell Biology
- Gene Therapy
- Regenerative Medicine
Background:
- Induced pluripotent stem (iPS) cells hold promise for regenerative medicine.
- Efficient gene transfer is crucial for differentiating iPS cells into functional cell types.
- Detailed transduction characteristics of iPS cells remain underexplored.
Purpose of the Study:
- To develop an efficient adenovirus (Ad) vector-mediated gene transduction system for mouse iPS cells.
- To investigate the potential of this system for enhancing iPS cell differentiation.
- To assess the utility of Ad vector-mediated transient gene expression for therapeutic applications.
Main Methods:
- Utilized an Ad vector with cytomegalovirus enhancer/beta-actin (CA) promoters for gene delivery.
- Applied the transduction system to mouse iPS cells, comparing efficiency with embryonic stem (ES) cells.
- Exogenously expressed PPARγ and Runx2 genes in iPS cells to promote specific differentiation pathways.
Main Results:
- The Ad vector demonstrated efficient transgene transduction in mouse iPS cells, similar to ES cells.
- The CA promoter exhibited potent transduction ability in iPS cells.
- Ad vector-mediated expression of PPARγ enhanced adipocyte differentiation, while Runx2 enhanced osteoblast differentiation.
Conclusions:
- Adenovirus vector-mediated transient gene transduction is sufficient to promote cellular differentiation in iPS cells.
- The developed Ad vector transduction system is a valuable tool for iPS cell-based therapeutic applications.
- This method facilitates targeted differentiation of iPS cells for regenerative medicine.
More Related Videos
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...